208 related articles for article (PubMed ID: 22429295)
21. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
22. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
23. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
[TBL] [Abstract][Full Text] [Related]
24. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
25. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111
[TBL] [Abstract][Full Text] [Related]
26. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands.
Guo XL; Sun SZ; Wang WX; Wei FC; Yu HB; Ma BL
Int J Oral Maxillofac Surg; 2007 Apr; 36(4):350-3. PubMed ID: 17223311
[TBL] [Abstract][Full Text] [Related]
27. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China.
Zhang AH; Bin HH; Pan XL; Xi XG
J Toxicol Environ Health A; 2007 Jun; 70(11):970-5. PubMed ID: 17479413
[TBL] [Abstract][Full Text] [Related]
29. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese.
Lin SC; Chang KW; Chang CS; Liu TY; Tzeng YS; Yang FS; Wong YK
J Oral Pathol Med; 2000 Apr; 29(4):159-66. PubMed ID: 10766393
[TBL] [Abstract][Full Text] [Related]
30. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
31. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
Ran R; Cao XA; Tian Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
[TBL] [Abstract][Full Text] [Related]
32. Prognostic importance of site in squamous cell carcinoma of the buccal mucosa.
Shaw RJ; McGlashan G; Woolgar JA; Lowe D; Brown JS; Vaughan ED; Rogers SN
Br J Oral Maxillofac Surg; 2009 Jul; 47(5):356-9. PubMed ID: 19054598
[TBL] [Abstract][Full Text] [Related]
33. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
34. [Study of p16INK4/CDKN2 gene homozygous deletions and point mutation in squamous cell carcinoma of buccal mucosa].
Dong YY; Wang J; Dong FS; Wang X; Zhang YH; Guo LH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2006 Aug; 24(4):362-5. PubMed ID: 16999361
[TBL] [Abstract][Full Text] [Related]
35. The prognostic relevance of p16 inactivation in head and neck cancer.
Koscielny S; Dahse R; Ernst G; von Eggeling F
ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):30-6. PubMed ID: 17085950
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
37. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
[TBL] [Abstract][Full Text] [Related]
38. Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association.
Chen SF; Yu FS; Chang YC; Fu E; Nieh S; Lin YS
J Oral Pathol Med; 2012 Jan; 41(1):9-15. PubMed ID: 21595750
[TBL] [Abstract][Full Text] [Related]
39. [Multiple tumor suppressor 1/p16 gene alterations in human esophageal squamous-cell carcinoma: clinical significance and regional difference].
Lü G; Chen X; Cao W
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):359-62. PubMed ID: 11776574
[TBL] [Abstract][Full Text] [Related]
40. [The relationship of p53 gene mutation to cell differentiation and metastasis of laryngeal squamous cell carcinoma].
Zhang X; Wang L; Liu S; Ouyang X; Liang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):61-3. PubMed ID: 11836691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
